{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:55:24Z","timestamp":1771592124321,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.nucmedbio.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T21:00:49Z","timestamp":1372712449000},"page":"764-775","source":"Crossref","is-referenced-by-count":24,"title":["[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: Impact of epilepsy and drug-responsiveness"],"prefix":"10.1016","volume":"40","author":[{"given":"Stina","family":"Syv\u00e4nen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Russmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike","family":"Labots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Zellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolph","family":"van Kooij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth C.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob A.","family":"Voskuyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Koepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Potschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0005","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.2174\/138161211797440212","article-title":"Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected","volume":"17","author":"Loscher","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1528-1167.2010.02585.x","article-title":"Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?","volume":"51","author":"Potschka","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nbd.2010.04.006","article-title":"Association between temporal lobe P-glycoprotein expression and seizure recurrence after surgery for pharmacoresistant temporal lobe epilepsy","volume":"39","author":"Kwan","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0020","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S1053-8119(03)00405-1","article-title":"Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET","volume":"20","author":"Bart","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0025","first-page":"2411","article-title":"A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier","volume":"59","author":"Hendrikse","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clpt.2005.01.022","article-title":"Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography","volume":"77","author":"Sasongko","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0035","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.neuroimage.2006.05.047","article-title":"Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET","volume":"32","author":"Syv\u00e4nen","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2967\/jnumed.108.058453","article-title":"Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein","volume":"50","author":"Seneca","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0045","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1021\/jm800510m","article-title":"Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function","volume":"51","author":"Lazarova","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0050","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2174\/156802610792927997","article-title":"Using PET studies of P-gp function to elucidate mechanisms underlying the disposition of drugs","volume":"10","author":"Syv\u00e4nen","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0055","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awh437","article-title":"Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures","volume":"128","author":"Volk","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jlcr.2580220603","article-title":"Production of 11C-labelled quinidine and tamoxifen","volume":"22","author":"van Haver","year":"1985","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0065","doi-asserted-by":"crossref","first-page":"S1052","DOI":"10.1002\/jlcr.25804401375","article-title":"A complete multipurpose, low cost, fully automated and GMP compliant radiosynthesis system","volume":"44","author":"Windhorst","year":"2001","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0883-2889(92)90012-4","article-title":"A simple synthesis of [11C]methyl triflate","volume":"43","author":"Jewett","year":"1992","journal-title":"Int J Rad Appl Instrum A"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.nucmedbio.2009.03.004","article-title":"Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats","volume":"36","author":"Luurtsema","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2007.05172.x","article-title":"Targeting epileptogenesis-associated induction of neurogenesis by enzymatic depolysialylation of NCAM counteracts spatial learning dysfunction but fails to impact epilepsy development","volume":"105","author":"Pekcec","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","article-title":"Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats","volume":"51","author":"Brandt","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0920-1211(03)00114-1","article-title":"Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats","volume":"55","author":"Brandt","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0013-4694(72)90178-2","article-title":"Modification of seizure activity by electrical stimulation. 3. Mechanisms","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0100","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2010.00765.x","article-title":"Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy","volume":"160","author":"Schlichtiger","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0105","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1528-1167.2010.02671.x","article-title":"Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy","volume":"51","author":"Bartmann","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0110","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1088\/0031-9155\/52\/5\/019","article-title":"Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner","volume":"52","author":"de Jong","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1088\/0031-9155\/53\/1\/007","article-title":"Impact of attenuation correction strategies on the quantification of High Resolution Research Tomograph PET studies","volume":"53","author":"van Velden","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2967\/jnumed.108.058628","article-title":"HRRT versus HR+human brain PET studies: an interscanner test-retest study","volume":"50","author":"van Velden","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: A free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/580717","article-title":"Reproducible Analysis of Rat Brain PET Studies Using an Additional [(18)F]NaF Scan and an MR-Based ROI Template","volume":"580717","author":"Buiter","year":"2012","journal-title":"Int J Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0140","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/jpet.109.152520","article-title":"Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation","volume":"330","author":"Pekcec","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0145","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.neuropharm.2009.01.009","article-title":"Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition","volume":"56","author":"Zibell","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuroscience.2003.10.012","article-title":"Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures","volume":"123","author":"Volk","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2003.12.009","article-title":"Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats","volume":"58","author":"Volk","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1369\/jhc.4A6451.2005","article-title":"Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables","volume":"53","author":"Volk","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0165","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2174\/138920011798356980","article-title":"PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo","volume":"12","author":"Mairinger","year":"2011","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/cn3001729","article-title":"Advances in PET imaging of P-glycoprotein function at the blood-brain barrier","volume":"4","author":"Syv\u00e4nen","year":"2013","journal-title":"ACS Chem Neurosci."},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s13318-011-0046-9","article-title":"Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer","volume":"36","author":"Patil","year":"2011","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0180","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1073\/pnas.85.10.3580","article-title":"ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells","volume":"85","author":"Horio","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1208\/s12248-011-9318-1","article-title":"Alteration in P-glycoprotein functionality affects intrabrain distribution of quinidine more than brain entry-a study in rats subjected to status epilepticus by kainate","volume":"14","author":"Syv\u00e4nen","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0195","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2174\/156802610792928022","article-title":"Substrates, inhibitors and activators of P-glycoprotein: candidates for radiolabeling and imaging perspectives","volume":"10","author":"Colabufo","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0200","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1016\/j.bmc.2010.06.057","article-title":"Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor","volume":"18","author":"Bauer","year":"2010","journal-title":"Bioorg"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0205","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1021\/jm900940f","article-title":"Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier","volume":"52","author":"D\u00f6rner","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0210","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays Biochem"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0026-895X(25)13129-5","article-title":"Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog","volume":"33","author":"Akiyama","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0225","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/0006-2952(95)02073-X","article-title":"Interaction of drugs with P-glycoprotein in brain capillaries","volume":"50","author":"Jette","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0230","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.22311","article-title":"Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy","volume":"60","author":"Heinemann","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.nucmedbio.2013.05.008_bb0235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.107.121178","article-title":"Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats","volume":"322","author":"van Vliet","year":"2007","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980511300111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980511300111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T12:46:57Z","timestamp":1746017217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980511300111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S096980511300111X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.05.008","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}